NDC 71656-071-08 - Tofacitinib
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71656-071
- Requested NDC
- 71656-071-08
- Package NDCs from labels
- 71656-071-08
- Manufacturer
- Saptalis Pharmaceuticals, LLC.
- Effective date
- 2026-10-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Tofacitinib - Saptalis Pharmaceuticals, LLC. | Saptalis Pharmaceuticals, LLC. | 2026-10-15 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tofacitinib | TOFACITINIB | Novadoz Pharmaceuticals LLC | 253635c8-1ea7-41ba-b216-dea5e3305c47 | 2026-09-01 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| TOFACITINIB | TOFACITINIB | Novadoz Pharmaceuticals LLC | 327f6b60-1a5d-49e6-acff-18603d0ee9d0 | 2026-08-20 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| Tofacitinib | TOFACITINIB | Edenbridge Pharmaceuticals LLC. | 576722e5-6639-452d-a5c3-33a064f19481 | 2026-08-17 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| tofacitinib | TOFACITINIB | Zydus Pharmaceuticals USA Inc. | 179ffbb2-bedc-40e6-b77b-33d4f7832172 | 2026-08-07 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| Tofacitinib | TOFACITINIB | Macleods Pharmaceuticals Limited | 9b654f0d-7705-4880-9e9d-ad3a51e56b56 | 2026-08-06 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| Tofacitinib | TOFACITINIB | AvKARE | 5751321a-c904-44ae-e063-6394a90a2654 | 2026-07-23 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| TOFACITINIB CITRATE | TOFACITINIB CITRATE | Radha Pharmaceuticals, Inc. | 141ab3eb-982b-4242-89db-6ddce5be0c40 | 2026-07-21 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| TOFACITINIB CITRATE | TOFACITINIB CITRATE | ScieGen Pharmaceuticals, INC. | 11d08738-efa3-4474-8eda-812bc04adfbb | 2026-07-21 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| TOFACITINIB | TOFACITINIB | Aurobindo Pharma Limited | e54b186f-e42a-4477-939c-8dd331045fbe | 2026-07-17 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| TOFACITINIB | TOFACITINIB | Aurobindo Pharma Limited | 50962b08-99dd-ae73-e063-6394a90ad1eb | 2026-07-17 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| TOFACITINIB | TOFACITINIB | IPG Pharmaceuticals, Inc | cd1b61bf-de03-4198-89f6-f3952b79d2c2 | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| SKIN TAG REMOVER | SALICYLIC ACID | Guangzhou ChuanMa International Trading Co.,Ltd. | 3a5e2105-7125-183c-e063-6394a90ae879 | 2026-07-02 | Warnings | 33X04XA5AT |
| WART SKIN TAG REMOVER | SALICYLIC ACID | Guangzhou ChuanMa International Trading Co.,Ltd. | 3a5b64a3-b19e-8b1a-e063-6294a90a6641 | 2026-07-02 | Warnings | 33X04XA5AT |
| tofacitinib solution | TOFACITINIB | Hikma Pharmaceuticals USA Inc. | d9cf18a9-e825-49ac-b080-68957c0e79ae | 2026-07-01 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| TOFACITINIB | TOFACITINIB | Orient Pharma Co., Ltd. Yunlin Plant | 5617a652-a78e-74b1-e063-6394a90a31c7 | 2026-06-30 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| Chemstat | GLYCERINUM, TARAXACUM OFFICINALE, PHYTOLACCA DECANDRA, ARSENICUM ALBUM, BOVISTA, CARBO VEGETABILIS, CARBONEUM SULPHURATUM, COFFEA CRUDA, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, SULPHUR, ACETYLSALICYLICUM ACIDUM, FORMALINUM, GLONOINUM, INSULINUM (HUMAN), LITHIUM CARBONICUM, TEREBINTHINA, THYROIDINUM (SUIS), ACETICUM ACIDUM, BENZOICUM ACIDUM, BENZYL ALCOHOL, BORICUM ACIDUM, CHLORINUM, CORTISONE ACETICUM, EUGENOL, FOLLICULINUM, ISOPROPYL PALMITATE, LACTICUM ACIDUM, | Energique, Inc. | 2e361b50-9268-4053-b13c-93af64549848 | 2026-06-25 | Warnings | VCQ006KQ1E |
| Tofacitinib | TOFACITINIB | AvKARE | 5502f252-2b39-2cfd-e063-6394a90a8a48 | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| Tofacitinib | TOFACITINIB | Ajanta Pharma USA Inc. | 024bb9f2-8c26-4d9d-a33b-eb3c0a7c59ed | 2026-06-05 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| TOFACITINIB | TOFACITINIB | Somerset Therapeutics, LLC | 2726c2b0-c763-4635-ac6b-4334c3a5a8bc | 2026-06-02 | Boxed warning, Warnings, Adverse reactions | O1FF4DIV0D |
| tofacitinib | TOFACITINIB | Zydus Lifesciences Limited | f4d0e580-74a8-496e-89a2-d74478c946bf | 2026-05-29 | O1FF4DIV0D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.